YS Biopharma (YS) Stock Analysis

What YS Biopharma does

YS Biopharma Co., Ltd., a biopharmaceutical firm established in Beijing, China, in 2002, specializes in the discovery, development, production, and commercialization of vaccines and therapeutic biologics. Their primary focus is on addressing infectious diseases and cancer. Central to their efforts is a proprietary PIKA immunomodulating technology platform, which supports the creation of preventive and therapeutic biologics for conditions such as Rabies, Coronavirus, Hepatitis B, Influenza, and Shingles. The company extends its operations across multiple countries, including China, the United States, Singapore, the United Arab Emirates, and the Philippines.

Key metrics

ETFs linked to YS

Broad-market and Healthcare sector ETFs an investor holding YS Biopharma is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how YS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for YS Biopharma?

YS Biopharma trades under the ticker YS on NASDAQ.

Which exchange is YS listed on?

YS is listed on NASDAQ.

What sector does YS Biopharma operate in?

YS Biopharma is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze YS in a portfolio?

PortView shows YS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.